Clinical trial
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
NCT00220493 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00220493 |
|---|---|
| Title | Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients |
| Official title | Clinical Study Protocol: Evaluation of the Efficiency of Ritalin in Multiple Sclerosis Patients |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive |
| Intervention type | Drug |
| Interventions | Ritalin |
| Enrollment | 80 |
| Start date | Jun 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 5, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: